News & Events about Moderna Inc.
Moderna, Inc. (NASDAQ:MRNA Get Rating) Director Noubar Afeyan sold 10,000 shares of the companys stock in a transaction on Wednesday, January 25th. The shares were sold at an average price of $194.33, for a total transaction of $1,943,300.00. Following the completion of the transaction, the director...
Designation based on positive topline data from the ConquerRSV Phase 3 pivotal efficacy trial, which demonstrated vaccine efficacy of 83.7% against RSV lower respiratory tract disease, defined by 2 or more symptoms in older adultsCAMBRIDGE, MA / ACCESSWIRE / January 30, 2023 /Moderna, Inc...
Moderna, Inc. (NASDAQ:MRNA Get Rating) CEO Stephane Bancel sold 40,000 shares of Moderna stock in a transaction that occurred on Thursday, January 19th. The shares were sold at an average price of $192.06, for a total transaction of $7,682,400.00. Following the sale, the chief executive ...
Elon Musk Reveals "Major Side Effects" After 2nd COVID Booster
Authored by Allen Zhong via The Epoch Times,
Elon Musksaid he felt like he was dying after his second COVID-19boostershot.
I had majorside effectsfrom my second booster shot, the new Twitter boss wrote in a social media post.
Felt ...
With US stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
read more...